NCT02840669View on ClinicalTrials.gov

A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions
Friedreich's Ataxia
Interventions
PROCEDURE

Cardiac magnetic resonance imaging (CMR)

PROCEDURE

Exercise-stress test

PROCEDURE

Echocardiography (ECHO)

PROCEDURE

Cardiac-related blood studies

Trial Locations (1)

75013

Hôpital Pitié-Salpêtrière, AP-HP, Paris

Sponsors
All Listed Sponsors
collaborator

Adverum Biotechnologies SAS, a wholly owned subsidiary of Adverum Biotechnologies, Inc.

UNKNOWN

lead

Adverum Biotechnologies, Inc.

INDUSTRY

NCT02840669 - A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study) | Biotech Hunter | Biotech Hunter